Volume 27, Issue 1

The Contraceptive Implant and the Injectable: A Comparison of Costs

A comparison of the relative costs of the injectable contraceptive (depot medroxyprogesterone acetate) and the hormonal implant (Norplant®) indicates that the implant is a less costly contraceptive option when it is used for its full five-year lifespan. Over a five-year period, the implant costs $107 annually, compared with $140 per year for the injectable. However, if a woman discontinues the implant before she has used it for at least four years, the injectable becomes the less costly option. Relatively high continuation rates--around 95% annually--are necessary to make the implant the more cost-effective contraceptive method.

Article in full text

The views expressed in this publication do not necessarily reflect those of the Guttmacher Institute.

Perspectives on Sexual and Reproductive Health

Support Our Work

Your support enables the Guttmacher Institute to advance sexual and reproductive health and rights in the United States and worldwide through our interrelated program of research, public education and policy analysis.